Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Letendre

Showing results (31-40 of 269) with videos related to

Pageof 27
Sort By:
Current HIV/AIDS Reports|November 15, 2021
Soluble Biomarkers of Cognition and Depression in Adults with HIV Infection in the Combination Therapy EraAlbert M Anderson, Qing Ma, Scott L Letendre, et al.
Medical and Pediatric Oncology|January 1, 1985
Phase I study of VP-16 (etoposide) and amsacrine (AMSA) in the treatment of refractory acute leukemiaL Letendre, V Hinemann, H C Hoagland, et al.
BMC Infectious Diseases|July 13, 2014
Cytokine secretion from brain macrophages infected with human immunodeficiency virus in vitro and treated with raltegravirErick T Tatro, Benchawanna Soontornniyomkij, Scott L Letendre, et al.
Brain Pathology (Zurich, Switzerland)|May 15, 2003
Changing patterns in the neuropathogenesis of HIV during the HAART eraT D Langford, S L Letendre, G J Larrea, et al.
Mayo Clinic Proceedings|July 1, 1982
Treatment of adult acute lymphocytic leukemiaL Letendre, J P Colgan, V L Hineman, et al.
International Review of Psychiatry (Abingdon, England)|February 2, 2008
Role of psychiatric medications as adjunct therapy in the treatment of HIV associated neurocognitive disordersBeau M Ances, Scott L Letendre, Terry Alexander, et al.
Journal of Veterinary Pharmacology and Therapeutics|September 9, 2016
The intravenous and oral pharmacokinetics of afoxolaner and milbemycin oxime when used as a combination chewable parasiticide for dogsL Letendre, J Harriman, M Drag, et al.
Mayo Clinic Proceedings|February 1, 1992
Outcome of recipients of bone marrow transplants who require intensive-care unit supportB Afessa, A Tefferi, H C Hoagland, et al.
Cancer|October 1, 1984
Hepatocellular toxicity during the treatment of refractory acute leukemia with indicine N-oxideL Letendre, J Ludwig, J Perrault, et al.
Journal of Veterinary Pharmacology and Therapeutics|November 29, 2016
Safety evaluation of orally administered afoxolaner and milbemycin oxime in eight-week-old dogsM Drag, J Saik, J Harriman, et al.
Pageof 27

Showing results (31-40 of 269) with videos related to

Sort By:
Pageof 27
Current HIV/AIDS Reports|November 15, 2021
Soluble Biomarkers of Cognition and Depression in Adults with HIV Infection in the Combination Therapy EraAlbert M Anderson, Qing Ma, Scott L Letendre, et al.
Medical and Pediatric Oncology|January 1, 1985
Phase I study of VP-16 (etoposide) and amsacrine (AMSA) in the treatment of refractory acute leukemiaL Letendre, V Hinemann, H C Hoagland, et al.
BMC Infectious Diseases|July 13, 2014
Cytokine secretion from brain macrophages infected with human immunodeficiency virus in vitro and treated with raltegravirErick T Tatro, Benchawanna Soontornniyomkij, Scott L Letendre, et al.
Brain Pathology (Zurich, Switzerland)|May 15, 2003
Changing patterns in the neuropathogenesis of HIV during the HAART eraT D Langford, S L Letendre, G J Larrea, et al.
Mayo Clinic Proceedings|July 1, 1982
Treatment of adult acute lymphocytic leukemiaL Letendre, J P Colgan, V L Hineman, et al.
International Review of Psychiatry (Abingdon, England)|February 2, 2008
Role of psychiatric medications as adjunct therapy in the treatment of HIV associated neurocognitive disordersBeau M Ances, Scott L Letendre, Terry Alexander, et al.
Journal of Veterinary Pharmacology and Therapeutics|September 9, 2016
The intravenous and oral pharmacokinetics of afoxolaner and milbemycin oxime when used as a combination chewable parasiticide for dogsL Letendre, J Harriman, M Drag, et al.
Mayo Clinic Proceedings|February 1, 1992
Outcome of recipients of bone marrow transplants who require intensive-care unit supportB Afessa, A Tefferi, H C Hoagland, et al.
Cancer|October 1, 1984
Hepatocellular toxicity during the treatment of refractory acute leukemia with indicine N-oxideL Letendre, J Ludwig, J Perrault, et al.
Journal of Veterinary Pharmacology and Therapeutics|November 29, 2016
Safety evaluation of orally administered afoxolaner and milbemycin oxime in eight-week-old dogsM Drag, J Saik, J Harriman, et al.
Pageof 27